Bioavailable curcumin matches prescription drug for joint health benefits

Bioavailable curcumin matches prescription
drug for joint health benefits
Supplements of a patented, high bioavailability curcumin may match a prescription rheumatoid arthritis drug for joint health benefits, but with fewer side effects, suggests new data. 

Eight weeks of 1 gram per day of the patented curcumin ingredient BCM-95 provided the same reductions in swelling and pain as 100 milligrams per day of the prescription drug diclofenac sodium, according to findings published in Phytotherapy Research.
In addition, Dr Ajay Goel from Baylor University Medical Center (USA) and Dr Binu Chandran from the Nirmala Medical Centre (India) report that there were no drop outs due to adverse effects in the curcumin group, but 14% of participants in the diclofenac sodium group withdrew due to adverse effects.
“The drugs used for people with rheumatoid arthritis can have severe adverse effects,” explained Goel. “Our study is the first to demonstrate the safety and effectiveness of curcumin in patients with active rheumatoid arthritis, and highlights the need for future large-scale trials to further validate these findings in patients with rheumatoid arthritis and other arthritic conditions.”

Try This Curcumin with BCM-95

To read more about joint health, glucosamine, curcumin and the anti-inflammatory effects click here

Bottom Line is:

“Our observations that curcumin alone was able to alleviate symptoms of rheumatoid arthritis in this study are quite encouraging, and these results provide an ideal springboard for investigating the potential of curcumin in other chronic diseases arising in the setting of dysregulated chronic inflammation."